secwatch / observer
8-K filed December 14, 2021, 6:59 PM ET ticker GUER CIK 0001832487
leadership confidence high sentiment neutral materiality 0.40

Samuel Funchess resigns from Guerrilla RF board, to become senior executive Jan 1, 2022

Guerrilla RF, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Samuel Funchess, Sr.

Director
GUER · Guerrilla RF, Inc.
Effective
2022-01-01
Filed
December 14, 2021, 6:59 PM ET
On December 8, 2021, Samuel Funchess, Sr. gave notice of his resignation from the Board of Directors of Guerrilla RF, Inc.
Appointed

Samuel Funchess, Sr.

Senior Executive
GUER · Guerrilla RF, Inc.
Effective
2022-01-01
Filed
December 14, 2021, 6:59 PM ET
Mr. Funchess will continue to serve as a director of the Company until January 1, 2022, subsequent to which, he has agreed to commence a senior executive position at the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Samuel Funchess, Sr. resigned as Director at Guerrilla RF, Inc..

Action
resigned
Role
Director
Exact text from the filing
On December 8, 2021, Samuel Funchess, Sr. gave notice of his resignation from the Board of Directors of Guerrilla RF, Inc.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Samuel Funchess, Sr. was appointed as Senior Executive at Guerrilla RF, Inc..

Action
appointed
Role
Senior Executive
Exact text from the filing
Mr. Funchess will continue to serve as a director of the Company until January 1, 2022, subsequent to which, he has agreed to commence a senior executive position at the Company.
View on SEC.gov

Guerrilla RF, Inc. filing history →

Source: SEC EDGAR
accession 0001213900-21-065111
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.